Federal contract award

W91YTZ21C0012

NEW - STD PATHOGENS MOLECULAR TESTING REAGEANTS

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Defense
OfficeW40M USA HCA
NAICS325413 — In-Vitro Diagnostic Substance Manufacturing
PSC6640 — Laboratory Equipment and Supplies
Parent award / vehicleNot reported
Set-asideNO SET ASIDE USED.
Pricing typeFIRM FIXED PRICE
Obligations$3.1M
Current contract value$3.1M
Potential contract value / ceiling$3.1M
Start dateOct 1, 2021
Current end dateSep 30, 2026
Potential end dateSep 30, 2026
Latest award activityFeb 10, 2026
Source loadedSep 19, 2026

Funding and modification history

Showing the latest 18 of 18 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Feb 10, 2026P00017$665.1KMOLECULAR TESTING REAGENTS
Jan 27, 2026P00016$0MOLECULAR TESTING REAGENTS
Jan 5, 2026P00015$0MOLECULAR TESTING REAGENTS
Aug 20, 2025P00014$-141.4KMOLECULAR TESTING REAGENTS COST PER REPORTABLE RESULT (CPRR)COST PER KIT (CPK)
Jul 10, 2025P00013$0MOLECULAR TESTING REAGENTS COST PER REPORTABLE RESULT (CPRR)COST PER KIT (CPK)
Nov 8, 2024P00012$665.1KFAF UMOD FY25 FUNDING REAGENTS TESTING WAMC
Sep 20, 2024P00011$0REAGENTS MOLECULAR TESTING - OPTION 1
Jan 9, 2024P00010$45.0KMOD - ADD OVERAGE CLINS
Dec 21, 2023P00009$0ADMIN MOD- PART NUMBER CHANGE
Dec 6, 2023P00008$0MOD - UNIT OF ISSUE CHANGE
Nov 7, 2023P00007$710.2KMOD - OY 2 FUNDING
May 10, 2023P00006$0MOD OY2 FY24
Oct 28, 2022P00005$-342.8KMOD FY22 DEOB STD REAGENTS
Oct 27, 2022P00004$710.2KMOD FUND FY23
Sep 20, 2022P00003$0MOD- ADMIN PART NUMBER CHANGE REAGENTS
May 6, 2022P00002$0MOD- OY1 EXERCISE FY23 SAF STD REAGENTS
Nov 5, 2021P00001$752.6KMOD FY22 FUNDING BASE YEAR MOLECULAR TESTING REAG
Aug 17, 20210$0NEW - STD PATHOGENS MOLECULAR TESTING REAGEANTS

Research next steps

  1. Check the stated set-aside against the solicitation and current certifications.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.